Barinthus Biotherapeutics Stock (NASDAQ: BRNS) stock price, news, charts, stock research, profile.
You can purchase shares of Barinthus Biotherapeutics (NASDAQ:BRNS) through any online brokerage.
Other companies in Barinthus Biotherapeutics’s space includes: Fortress Biotech (NASDAQ:FBIO), OS Therapies (AMEX:OSTX), CollPlant Biotechnologies (NASDAQ:CLGN), Precision BioSciences (NASDAQ:DTIL) and FibroBiologics (NASDAQ:FBLG).
Barinthus Biotherapeutics has a consensus price target of $5.17.
The stock price for Barinthus Biotherapeutics (NASDAQ: BRNS) is $1.02 last updated February 21, 2025 at 8:43 AM EST.
There are no upcoming dividends for Barinthus Biotherapeutics.
Barinthus Biotherapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.
There is no upcoming split for Barinthus Biotherapeutics.
Barinthus Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.